KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background KVLQT1 , the gene encoding the α-subunit of a cardiac potassium channel, is the most common cause of the dominant form of long-QT syndrome (LQT1-type), the Romano-Ward syndrome (RWS). The overall phenotype of RWS is characterized by a prolonged QT interval on the ECG and cardiac ventricular arrhythmias leading to recurrent syncopes and sudden death. However, there is considerable variability in the clinical presentation, and potential severity is often difficult to evaluate. To analyze the relationship between phenotypes and underlying defects in KVLQT1 , we investigated mutations in this gene in 20 RWS families originating from France. Methods and Results By PCR-SSCP analysis, 16 missense mutations were identified in KVLQT1 , 11 of them being novel. Fifteen mutations, localized in the transmembrane domains S2-S3, S4-S5, P, and S6, were associated with a high percentage of symptomatic carriers (55 of 95, or 58%) and sudden deaths (23 of 95, or 24%). In contrast, a missense mutation, Arg 555 Cys, identified in the C-terminal domain in 3 families, was associated with a significantly less pronounced QT prolongation (459±33 ms, n=41, versus 480±32 ms, n=70, P =.0012), and significantly lower percentages of symptomatic carriers (7 of 44, or 16%, P <.001) and sudden deaths (2 of 44, or 5%, P <.01). Most of the cardiac events occurring in these 3 families were triggered by drugs known to affect ventricular repolarization. Conclusions Our data show a wide KVLQT1 allelic heterogeneity among 20 families in which KVLQT1 causes RWS. We describe the first missense mutation in the C-terminal domain of KVLQT1, which is clearly associated with a fruste phenotype, which could be a favoring factor of acquired LQT syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel
Sanguinetti, M. C., Curran, M. E., Zou, A., Shen, J., Specter, P. S., Atkinson, D. L., & Keating, M. T. (1996) · Nature · doi:10.1038/384080a0 · Cited by 1,764
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J., Shen, J., Timothy, K. W., Vincent, G. M., de Jager, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-17 · Cited by 1,759
KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current
Barhanin, J., Lesage, F., Guillemare, E., Fink, M., Lazdunski, M., & Romey, G. (1996) · Nature · doi:10.1038/384078a0 · Cited by 1,614
Diagnostic criteria for the long QT syndrome. An update.
Schwartz, P. J., Moss, A. J., Vincent, G. M., & Crampton, R. S. (1993) · Circulation · doi:10.1161/01.cir.88.2.782 · Cited by 1,181
Neyroud, N., Tesson, F., Denjoy, I., Leibovici, M., Donger, C., Barhanin, J., Fauré, S., Gary, F., Coumel, P., Petit, C., et al. (1997) · Nature Genetics · doi:10.1038/ng0297-186 · Cited by 891
Self-citationThe long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
Jackman, W. M., Friday, K. J., Anderson, J. L., Aliot, E. M., Clark, M., & Lazzara, R. (1988) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(88)90014-x · Cited by 783
Browne, D. L., Gancher, S. T., Nutt, J. G., Brunt, E. R. P., Smith, E. A., Kramer, P., & Litt, M. (1994) · Nature Genetics · doi:10.1038/ng1094-136 · Cited by 777
Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
Roden, D. M., Lazzara, R., Rosen, M., Schwartz, P. J., Towbin, J., & Vincent, G. M. (1996) · Circulation · doi:10.1161/01.cir.94.8.1996 · Cited by 628
Molecular Basis of the Long-QT Syndrome Associated with Deafness
Splawski, I., Timothy, K. W., Vincent, G. M., Atkinson, D. L., & Keating, M. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705293362204 · Cited by 349
Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita)
George, A. L., Crackower, M. A., Abdalla, J. A., Hudson, A. J., & Ebers, G. C. (1993) · Nature Genetics · doi:10.1038/ng0493-305 · Cited by 283
Cited by
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Priori, S. G., Wilde, A. A., Horie, M., Cho, Y., Behr, E. R., Berul, C., Blom, N., Brugada, J., Chiang, C.-E., Huikuri, H., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.05.014 · Cited by 1,942
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Spectrum of Mutations in Long-QT Syndrome Genes: KVLQT1 , HERG , SCN5A , KCNE1 , and KCNE2
Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1178 · Cited by 1,231
Low Penetrance in the Long-QT Syndrome: Clinical Impact
Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999) · Circulation · doi:10.1161/01.cir.99.4.529 · Cited by 804
Long QT syndromes and torsade de pointes
Viskin, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02107-8 · Cited by 689
What Clinicians Should Know About the QT Interval
Al-Khatib, S. M., LaPointe, N. M. A., Kramer, J. M., & Califf, R. M. (2003) · JAMA · doi:10.1001/jama.289.16.2120 · Cited by 667
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 554
Voltage-Gated Ion Channels and Hereditary Disease
Lehmann-Horn, F., & Jurkat-Rott, K. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1317 · Cited by 550
Liang, P., Lan, F., Lee, A. S., Gong, T., Sanchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J. W., Wang, P. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001883 · Cited by 537
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Shieh, C.-C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01469-8 · Cited by 518
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479
Kannankeril, P., Roden, D. M., & Darbar, D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003723 · Cited by 440
The genetic basis of long QT and short QT syndromes: A mutation update
Hedley, P. L., Jørgensen, P., Schlamowitz, S., Wangari, R., Moolman-Smook, J., Brink, P. A., Kanters, J. K., Corfield, V. A., & Christiansen, M. (2009) · Human Mutation · doi:10.1002/humu.21106 · Cited by 429
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Wilke, R. A., Lin, D. W., Roden, D. M., Watkins, P. B., Flockhart, D., Zineh, I., Giacomini, K. M., & Krauss, R. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2423 · Cited by 391
Drug‐Induced Torsades de Pointes and Implications for Drug Development
FENICHEL, R. R., MALIK, M., ANTZELEVITCH, C., SANGUINETTI, M., RODEN, D. M., PRIORI, S. G., RUSKIN, J. N., LIPICKY, R. J., CANTILENA, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 346
Volders, P. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00022-5 · Cited by 333
Pharmacogenomics: Unlocking the Human Genome for Better Drug Therapy
McLeod, H. L., & Evans, W. E. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.101 · Cited by 331
The long QT syndromes: genetic basis and clinical implications
Chiang, C.-E., & Roden, D. M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00716-6 · Cited by 328
Long QT syndrome: reduced repolarization reserve and the genetic link
RODEN, D. M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01589.x · Cited by 322
The QT syndromes: long and short
Morita, H., Wu, J., & Zipes, D. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61307-0 · Cited by 317
Ponti, F. D., Poluzzi, E., Cavalli, A., Recanatini, M., & Montanaro, N. (2002) · Drug Safety · doi:10.2165/00002018-200225040-00004 · Cited by 309
Roden, D. M., Balser, J. R., George Jr, A. L., & Anderson, M. E. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.083101.145105 · Cited by 305
NAPOLITANO, C., SCHWARTZ, P. J., BROWN, A. M., RONCHETTI, E., BIANCHI, L., PINNAVAIA, A., ACQUARO, G., & PRIORI, S. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00033.x · Cited by 300
Crotti, L., Celano, G., Dagradi, F., & Schwartz, P. J. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-18 · Cited by 297
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II
Priori, S. G., Barhanin, J., Hauer, R. N. W., Haverkamp, W., Jongsma, H. J., Kleber, A. G., McKenna, W. J., Roden, D. M., Rudy, Y., Schwartz, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.4.518 · Cited by 294
Self-citationThe genetic basis of variability in drug responses
Roden, D. M., & George Jr, A. L. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd705 · Cited by 292
Paulussen, A. D. C., Gilissen, R. A. H. J., Armstrong, M., Doevendans, P. A., Verhasselt, P., Smeets, H. J. M., Schulze-Bahr, E., Haverkamp, W., Breithardt, G., Cohen, N., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0522-z · Cited by 280
Genetics of acquired long QT syndrome
Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 256
Macrolide Antibiotics and the Risk of Cardiac Arrhythmias
Albert, R. K., & Schuller, J. L. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0385ci · Cited by 163
Exaggerated QT prolongation after cardioversion of atrial fibrillation
Choy, A. M. J., Darbar, D., Dell’Orto, S., & Roden, D. M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00226-0 · Cited by 89
IKr channel blockade to unmask occult congenital long QT syndrome
Jeyaraj, D., Abernethy, D. P., Natarajan, R. N., Dettmer, M. M., Dikshteyn, M., Meredith, D. M., Patel, K., Allareddy, R. R., Lewis, S. A., & Kaufman, E. S. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2007.08.031 · Cited by 18
Metadata
- Authors
- Donger, C., Denjoy, I., Berthet, M., Neyroud, N., Cruaud, C., Bennaceur, M., Chivoret, G., Schwartz, K., Coumel, P., & Guicheney, P.
- Venue
- Circulation
- Published
- 1997-11-04
- Volume
- 96
- Issue
- 9
- Pages
- 2778-2781
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2046508780
- Cited by
- 348
- References
- 19
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.